Isomorphic Labs Appoints Dr. Ben Wolf as Chief Medical Officer

Jun 17, 2025
Isomorphic Labs has appointed Dr. Ben Wolf as Chief Medical Officer and established a new US presence in Cambridge, Massachusetts, announced in a press release.

Isomorphic Labs has appointed Dr. Ben Wolf as Chief Medical Officer and established a new US presence in Cambridge, Massachusetts, announced in a press release. Dr. Wolf, who brings nearly 20 years of biopharmaceutical experience, will lead the company's efforts in translating AI-driven drug discoveries into medicines.

Dr. Wolf will be based in the newly established Cambridge location, which will serve as a key operational hub. This expansion follows the company's recent $600 million funding round, aimed at advancing its AI drug design engine. Dr. Wolf's previous roles include Chief Medical Officer at Relay Therapeutics and KSQ Therapeutics, where he led clinical trials and advanced therapeutic pipelines.

The appointment of Dr. Wolf and the establishment of the US presence underscore Isomorphic Labs' commitment to leveraging AI for drug discovery and development. The Cambridge hub will work closely with teams in London and Lausanne, enhancing the company's global operations.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Guide
Specialist Ambient Medical Scribe Vendors

Specialist Ambient Medical Scribe Vendors

AI scribes that turn medical consultations into draft clinical notes

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.